Status Complete
Estimated value without VAT 30 000 MDL
  • Winner: graficdesign
  • Cost: 17 713 MDL
  • Saved: 40.96 %
  • Of participants: 2
Period of clarifications: 4.12.18 12:26 - 6.12.18 12:25
Submission of proposals: 6.12.18 12:25 - 8.12.18 12:25
Auction start date: 10 Dec 2018 15:53

Supplier technical support:

(+373) 79999801

formulare medicale
Information about customer
Fiscal code/IDNO
Address
MD-2048, Moldova, Chisinau, Chisinua, Grenoble 147
Web site
---
The contact person
Full name
Ilie Sochirca
Contact phone
---
Purchase data
Type of procedure
Low value procedure
Estimated value (without VAT)
30 000 MDL
The minimum downward of the price
120 MDL
Date of last modifications
1 Feb 2019 16:08
ID
6a8319ea21014332b686214f5bf1f076
List of positions
1)
Title
formulare medicale CPV: 30000000-9 - Office and computing machinery, equipment and supplies except furniture and software packages
Delivery address: MD-2048, MD, Chisinau, Chisinua, Grenoble 147
Delivery period: 18 Dec 2018 12:25 - 24 Dec 2018 12:26
Quantity: 26
Unit of measurement: piece
Documents of the procurement procedure
Participants list
Qualification
1
Participant(s) name(s):

GIBEONA - PLUS

Normalized price: 11 999 MDL
Status: Disqualified
Gibiona -Plus
Cererea-anunţul conţine lista formularelor necesare, însă oferta a fost întocmită necorespunyător, oferindune servicii tipografice
Qualification documents
Documents folder missing
Documents provided with the proposal
2
Participant(s) name(s):

graficdesign

Tender completed
Normalized price: 17 713 MDL
Status: Winner
Grafic Design
Oferta corespunde cererii
Qualification documents
Documents folder missing
Documents provided with the proposal
Auction
1
Participant(s) name(s): GIBEONA - PLUS
Normalized price: 11 999 MDL
Documents provided with the proposal
2
Participant(s) name(s): graficdesign
Normalized price: 17 713 MDL
Documents provided with the proposal
Contract
View contract
The history of the auction
View auction
Litigation
File an appeal
Unfortunately, questions can be asked only during the "Enquiry period" period.
Clarifications